Karen Chang

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 562 citations · Full text

Medicine, Oncology, Pharmacology +11

Long-term follow-up of branch-duct intraductal papillary mucinous neoplasms with No change in first 5 Years of diagnosis

Brian S. Lee, Andrew K. L. Nguyen, Timnit Tekeste et al. · Pancreatology · 2020 · 40 citations

Medicine, Oncology, Pathology +10

Quantitation of Rates of Transport, Metabolic Fluxes, and Cytoplasmic Levels of Inorganic Carbon in Maize Root Tips during K+ Ion Uptake

Karen Chang, Justin K. M. Roberts · PLANT PHYSIOLOGY · 1992 · 32 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +17

A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia.

Stéphanie Lheureux, Michael Cabanero, Mihaela Cristea et al. · Journal of Clinical Oncology · 2019 · 21 citations

Medicine, Oncology, Pharmacology +17

The effect of prophylactic hemoclips on the risk of delayed post-endoscopic mucosal resection bleed for upper and lower gastrointestinal lesions: a retrospective cohort study

Karen Chang, Brian S. Lee, Timnit Tekeste et al. · BMC Gastroenterology · 2020 · 12 citations · Full text

Medicine, Clinical Sciences, Surgery +17